Mereo BioPharma Group plc (AIM:MPH)
26.50
-0.50 (-1.85%)
At close: Dec 17, 2020
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of 44.63 million as of September 25, 2026. Its market cap has decreased by -79.04% in one year.
Market Cap
44.63M
Enterprise Value
22.66M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
26.50
ChartMarket Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from 96.41M to 44.63M, a decrease of -53.71%. That is a compound annual growth rate of -9.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 44.63M | -9.42% |
| Dec 31, 2025 | 49.27M | -88.62% |
| Dec 31, 2024 | 433.05M | 70.57% |
| Dec 29, 2023 | 253.89M | 249.41% |
| Dec 30, 2022 | 72.66M | -43.40% |
| Dec 31, 2021 | 128.39M | -27.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Naked Wines | 42.80M |
| Gattaca | 42.63M |
| Kromek Group | 42.59M |
| Corcel | 41.43M |
| Revolution Beauty Group | 41.31M |
| One Health Group | 40.80M |
| LendInvest | 40.43M |
| Oxford Metrics | 40.30M |